Lindbrook Capital »

Voyager Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $438 75 5.85

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Golub Cap Bdc Cef (GBDC)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Amazon.com Stock (AMZN)
Broadcom Stock (AVGO)
Ishares Russell 1000 Value Etf Etf (IWD)
Powershares Qqq Tr Etf (QQQ)
Google Stock (GOOGL)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Voyager Therapeutics

Armistice Capital
BlackRock
EcoR1 Capital
Vanguard Group
Farallon Capital Management
Dimensional Fund Advisors
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
T. Rowe Price Associates
Dr. Jeffrey R. Jay, M.D.
Vestal Point Capital
Morgan Stanley
Northern Trust
Prudential Financial

View all funds holding Voyager Therapeutics